ArticleJCI insight2023

Mutant RB1 enhances therapeutic efficacy of PARPis in lung adenocarcinoma by triggering the cGAS/STING pathway.

Qi Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.